Whistler, Toni, Unger, Elizabeth R, Nisenbaum, Rosane et al. · Journal of translational medicine · 2003 · DOI
This study looked at blood samples from people with ME/CFS to see if the disease might actually be several different conditions rather than one. Researchers found that when they grouped patients by how their illness started, certain genes were turned on or off differently. These genes are involved in how the body produces energy, particularly through breaking down sugars and other molecules. This suggests that ME/CFS patients may have different underlying problems with their body's energy production systems.
This study provides early molecular evidence that ME/CFS is not a single uniform condition, which may explain why patients respond differently to treatments and have varied symptom presentations. Identifying distinct metabolic abnormalities based on illness onset could eventually lead to better diagnostic subtyping and more targeted treatments for different patient groups.
This study does not prove that metabolic abnormalities cause ME/CFS symptoms or determine whether these gene expression changes are primary disease mechanisms or secondary responses to illness. It cannot establish causation from correlation alone, and findings require functional validation and replication in larger, better-powered cohorts. The cross-sectional design prevents determination of whether gene expression changes persist over time or predict disease progression.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Contribute
Private, reviewed by a human. Not a public comment thread.